Stock
Kiniksa Pharmaceuticals Intern
Ticker not mapped · held by 2 managers
Reported value
$24.5K
Holders
2
+1 new · −0 exited
Holders’ est. mark
$104
Price effect on 1 books still in the name
Largest holder
$23.7K
Uniplan Investment Counsel, Inc.
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 493 | $23.7K | — | New |
| HARBOR CAPITAL ADVISORS, INC. | 15.1K | $726 | $104 | Cut−$163 |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.